vers la météo de la validation par utilisateur

Ingenuity287


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 0 - PMID ?

In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 1
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 2
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 3
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 4
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 5
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 6
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 7
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 8
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 9
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 10
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 11
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 12
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 13
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 14
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 15
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 16
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 17
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 18
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 19
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 20
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 21
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 22
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 23
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 24
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 25
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 26
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 27
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 28
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 29
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 30
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 31
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 32
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 33
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 34
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 35
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 36
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 37
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 38
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 39
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 40
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 41
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 42
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 43
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 44
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 45
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 46
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 47
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 48
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 49
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 50
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 51
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 52
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 53
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 54
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 55
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 56
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 57
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 58
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 59
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 60
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 61
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 62
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 63
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 64
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 65
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 66
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 67
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 68
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 69
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 70
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 71
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 72
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 73
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 74
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 75
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 76
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 77
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 78
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 79
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 80
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 81
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 82
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 83
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 84
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 85
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 86
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 87
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 88
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 89
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 90
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 91
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 92
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 93
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 94
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 95
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 96
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 97
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 98
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 99
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 100
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 101
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 102
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 103
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 104
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 105
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 106
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 107
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 108
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 109
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 110
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 111
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 112
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 113
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 114
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 115
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 116
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 117
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 118
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 119
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 120
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 121
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 122
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 123
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 124
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 125
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 126
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 127
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 128
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 129
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 130
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 131
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 132
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 133
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 134
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 135
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 136
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 137
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 138
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 139
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 140
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 141
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 142
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 143
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 144
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 145
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 146
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 147
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 148
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 149
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 150
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 151
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 152
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 153
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 154
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 155
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 156
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 157
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 158
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 159
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 160
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 161
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 162
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 163
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 164
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 165
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 166
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 167
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 168
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 169
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 170
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 171
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 172
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 173
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 174
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 175
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 176
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 177
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 178
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 179
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 180
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 181
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 182
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 183
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 184
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 185
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 186
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 187
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 188
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 189
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 190
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 191
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 192
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 193
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 194
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 195
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 196
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 197
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 198
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 199
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 200
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 201
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 202
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 203
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 204
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 205
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 206
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 207
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 208
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 209
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 210
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 211
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 212
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 213
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 214
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 215
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 216
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 217
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 218
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 219
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 220
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 221
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 222
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 223
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 224
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 225
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 226
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 227
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 228
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 229
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 230
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 231
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 232
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 233
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 234
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 235
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 236
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 237
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 238
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 239
                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)